Clinical manifestations of Behçet's disease: an analysis of 2147 patients A Gurler, A Boyvat, U Tursen Yonsei medical journal 38 (6), 423-427, 1997 | 539 | 1997 |
Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease U Tursen, A Gurler, A Boyvat International journal of dermatology 42 (5), 346-351, 2003 | 534 | 2003 |
Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study E Alpsoy, L Donmez, M Onder, S Gunasti, A Usta, Y Karincaoglu, B Kandi, ... British Journal of Dermatology 157 (5), 901-906, 2007 | 358 | 2007 |
Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study Y Karincaoglu, M Borlu, SC Toker, A Akman, M Onder, S Gunasti, A Usta, ... Journal of the American Academy of Dermatology 58 (4), 579-584, 2008 | 241 | 2008 |
Clinical improvement in chronic plaque‐type psoriasis lesions after narrow‐band UVB therapy is accompanied by a decrease in the expression of IFN‐γ inducers–IL‐12, IL‐18 and IL‐23 G Piskin, U Tursen, RMR Sylva‐Steenland, JD Bos, MBM Teunissen Experimental dermatology 13 (12), 764-772, 2004 | 229 | 2004 |
The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients N Kundakci, Ü Türsen, MOA Babiker, E Gürgey International journal of dermatology 41 (4), 220-224, 2002 | 216 | 2002 |
The prevalence of pediculosis capitis in schoolchildren in Mersin, Turkey A Kokturk, K Baz, R Bugdayci, T Sasmaz, U Tursen, TI Kaya, G Ikizoglu International journal of dermatology 42 (9), 694-698, 2003 | 145 | 2003 |
Cutaneous manifestations in hospitalized patients diagnosed as COVID‐19 O Askin, RN Altunkalem, DD Altinisik, TK Uzuncakmak, U Tursen, ... Dermatologic Therapy 33 (6), e13896, 2020 | 100 | 2020 |
Oxidant/antioxidant status in patients with recurrent aphthous stomatitis MYB Cimen, TI Kaya, G Eskandari, U Tursen, G Ikizoglu, U Atik Clinical and Experimental Dermatology 28 (6), 647-650, 2003 | 97 | 2003 |
Cutaneous sıde‐effects of the potential COVID‐19 drugs Ü Türsen, B Türsen, T Lotti Dermatologic therapy 33 (4), e13476, 2020 | 95 | 2020 |
D‐penicillamine treatment for lipoid proteinosis TI Kaya, A Kokturk, U Tursen, G Ikizoglu, A Polat Pediatric dermatology 19 (4), 359-362, 2002 | 89 | 2002 |
Pathophysiology of the Behçet′ s Disease Ü Türsen Pathology research international 2012 (1), 493015, 2012 | 84 | 2012 |
Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease TI Kaya, U Tursen, A Gurler, H Dur Clinical and experimental dermatology 27 (6), 498-501, 2002 | 80 | 2002 |
The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment AC Yazici, U Tursen, DD Apa, G Ikizoglu, H Api, K Baz, B Tasdelen Archives of dermatological research 297, 249-255, 2005 | 74 | 2005 |
Relationship between ABO blood groups and skin cancers U Tursen, EN Tiftik, S Unal, O Gunduz, TI Kaya, H Camdeviren, G Ikizoglu Dermatology online journal 11 (3), 2005 | 67 | 2005 |
Cutaneous manifestations of COVID‐19: a review of the published literature ÖF Elmas, A Demirbaş, K Özyurt, M Atasoy, Ü Türsen Dermatologic therapy 33 (4), e13696, 2020 | 61 | 2020 |
Association between catechol-O-methyltransferase polymorphism and vitiligo. Ü Türsen, TI Kaya, ME Erdal, E Derici, Ö Gündüz, G Ikizoǧlu Archives of dermatological research 294 (3), 2002 | 61 | 2002 |
Psoriasis and COVID‐19: a narrative review with treatment considerations ÖF Elmas, A Demirbaş, Ö Kutlu, F Bağcıer, MS Metin, K Özyurt, N Akdeniz, ... Dermatologic Therapy 33 (6), e13858, 2020 | 55 | 2020 |
Treatment of lichen planopilaris with mycophenolate mofetil U Tursen, H Api, T Kaya, G Ikizoglu Dermatology online journal 10 (1), 2004 | 54 | 2004 |
Giant recurrent pyogenic granuloma on the face with satellitosis responsive to systemic steroids U Tursen, F Demirkan, G Ikizoglu Clinical and experimental dermatology 29 (1), 40-41, 2004 | 51 | 2004 |